Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

NCT00313885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia
Sleep
Chronic Pain

Interventions

DRUG: eplivanserin (SR46349)
DRUG: placebo

Sponsor

Sanofi